18. Spinocerebellar degeneration
59 clinical trials,   78 drugs   (DrugBank: 28 drugs),   44 drug target genes,   59 drug target pathways

Searched query = "Spinocerebellar degeneration", "SCD", "Spinocerebellar ataxia type I", "SCA1", "Spinocerebellar ataxia type II", "SCA2", "Spinocerebellar ataxia type III", "SCA3", "Machado-Joseph disease", "Spinocerebellar ataxia type VI", "SCA6", "Spinocerebellar ataxia type VII", "SCA7", "Spinocerebellar ataxia type X", "SCA10", "Spinocerebellar ataxia type XII", "SCA12", "Dentatorubural pallidoluysian atrophy", "Dentatorubropallidoluysial atrophy", "DRPLA", "Naito-Koyanagi disease", "Friedreich ataxia", "FRDA", "Ataxia with vitamin E deficiency", "AVED", "Early-onset ataxia with ocular motor ataxia and hypoalbuminemia", "EOAH"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2009-010865-22-IT
(EUCTR)
06/05/200916/04/2009An open-label, single treatment, safety and efficacy, long-term study of deferiprone in subjects with Friedreich?s ataxia - NDAn open-label, single treatment, safety and efficacy, long-term study of deferiprone in subjects with Friedreich?s ataxia - ND patients affected by Friedreich AtaxiaINN or Proposed INN: DeferiproneAPOPHARMA INC., TORONTO, ONTARIONULLNot RecruitingFemale: yes
Male: yes
74Belgium;France;Spain;Italy
2EUCTR2007-003331-23-IT
(EUCTR)
16/07/200810/07/2008A study investigating the safety and tolerability of deferiprone in patients with Friedreich's Ataxia - NDA study investigating the safety and tolerability of deferiprone in patients with Friedreich's Ataxia - ND patients affected by Friedreich Ataxia
MedDRA version: 9.1;Level: LLT;Classification code 10017374;Term: Friedreich's ataxia
Product Name: Deferiprone
INN or Proposed INN: Deferiprone
APOPHARMA INC., TORONTO, ONTARIONULLNot RecruitingFemale: yes
Male: yes
80United Kingdom;Belgium;France;Spain;Italy